What is Lynch syndrome?

Lynch syndrome is a hereditary condition that makes a person more likely to develop cancer. Other names for Lynch syndrome include Hereditary Nonpolyposis Colorectal Cancer syndrome (HNPCC) and Muir-Torre syndrome. Colorectal cancer and uterine (endometrial) cancer are the two cancers a person with Lynch syndrome is at greatest risk to develop; however, these risks and other cancer risks may be reduced through specialized medical care.

Lynch syndrome is one of the most common causes of hereditary cancer risk with approximately one in 270 people affected. Lynch syndrome causes about three to five percent of colon cancers and two to three percent of uterine cancers.

It is important to note that not every person with Lynch syndrome develops cancer, but the odds of developing cancer are much greater than average. Fortunately, interventions are available to carefully monitor for cancer as well as to reduce cancer risk. Within Penn Medicine's Gastrointestinal Cancer Genetics Program, the Lynch Syndrome Management Program has been specifically designed to help provide state-of-the-art, compassionate care and proactive health management for individuals and families with Lynch syndrome.

What causes Lynch syndrome?

Genes are instructions for how the body grows and functions. Our genes are inherited (passed down) from our parents. Some genes help determine traits like hair color or eye color. Other genes may increase or decrease the chance of disease, such as developing cancer.

A person with Lynch syndrome is born with a mutation (harmful genetic change) in one of the following genes: MLH1, MSH2, MSH6, PMS2 or EPCAM. Typically, these genes help the body prevent cancer from developing. When a mutation is present, the gene is unable to perform its normal role in cancer prevention, thus causing a person with Lynch syndrome to have a greater chance for cancer to develop.

What are the cancer risks related to Lynch syndrome?

Cancer Site Colorectal Cancer Endometrial (Uterine) Cancer
General Population Risk 4.2% 3.1%
MLH1 46-61% 34-54%
MSH2 & EPCAM 33-52% 21-57%
MSH6 10-44% 16-49%
PMS2 9-20% 13-26%
Cancer Site General Population Risk MLH1 Lynch Syndrome Risk
Colorectal Cancer 4.5% 46-49%
Endometrial Cancer 2.7% 43-57%
Gastric Cancer <1% 5-7%
Ovarian Cancer 1.3% 5-20%
Small Intestinal Cancer <1% Up to 11%
Pancreas Cancer 1.5% 6%
Bladder Cancer 2.5% 2-4%
Urothelial Cancer <1% Up to 5%
Biliary Tract Cancer <1% Up to 5%

Lynch syndrome management

An important way to decrease cancer risk in Lynch syndrome is through performing appropriate screening and implementation of risk-reduction strategies, such as colonoscopy.

With Penn Medicine's Lynch Syndrome Management Program, you will meet with a physician with expertise in Lynch syndrome on a yearly basis to review your personal medical history, genetic testing results, and family medical history in order to provide an individualized, comprehensive Lynch syndrome management plan. This plan will cover recommendations for cancer screening and/or risk reduction options, addressing risks for Lynch syndrome-associated cancers, including: gastrointestinal tract cancer (colorectal, gastric, small intestinal, pancreatic), gynecologic cancer (uterine and ovarian, if applicable), urinary tract cancer and skin cancer among others. The Lynch Syndrome Management Plan will also cover important topics, such as: chemoprevention (taking medications to decrease cancer risk), family planning, and genetic testing of potentially at-risk relatives.

Treatments at Penn Medicine

National Cancer Institute Designated Comprehensive Cancer Center badge on top of shot of hospital

Rated “exceptional” by The National Cancer Institute

Penn Medicine’s Abramson Cancer Center is a world leader in cancer research, patient care, and education. Our status as a national leader in cancer care is reflected in our continuous designation as a Comprehensive Cancer Center by the National Cancer Institute (NCI) since 1973, one of 7 such centers in the United States. The ACC is also a member of the National Comprehensive Cancer Network, one of a select few cancer centers in the U.S., that are working to promote equitable access to high-quality, advanced cancer care.

Related specialties

Patient stories

Volunteering for cancer research: an act of love

The Basser Center for BRCA is running an innovative cancer interception clinical trial that depends on volunteers with deep, personal ties to cancer.

Faith, fate, and families

At the Basser Center for BRCA at Penn, a unique philanthropic investment is making rapid progress toward preventing and treating heritable cancer.

New lungs, a new liver, and a new lease on life

Decades after a childhood diagnosis of cystic fibrosis, Donald traveled across the world to find transplant care he could trust at Penn Medicine.

Finding triple-negative breast cancer at 33, she chose ‘Team Penn’

Shocked to learn she had stage III breast cancer, Kate Korson knew just where to go. She flew home to Penn Medicine, where a clinical trial saved her life.

A patient’s mutation could save others from second skeleton

A patient who unknowingly grew up with a progressive bone-forming condition could help protect others from the grip of the disease.

A lifetime of worry eased with one infusion

After receiving gene therapy for hemophilia, a disease Curt Krouse had lived with for 57 years, his “life changed in 30 minutes.”

CNN anchor Kasie Hunt had brain surgery at Penn

Before starting her own daily news show, journalist Kasie Hunt came to Penn Medicine for a growing brain tumor that was causing painful headaches.

Essential tremor patient finds relief

When his essential tremor symptoms became severe, Jim McDevitt turned to Dr. Iahn Cajigas and the team at Penn Medicine for help.

ECMO saves recovering cancer survivor from lung failure

From cancer survivor to lung failure, Joey Porch’s journey took a miraculous turn with the help of the Penn Lung Rescue team

Patient puts national spotlight on cancer clinical trials

As Kate Korson recently shared on Good Morning America, both she and her mother participated in clinical trials at Abramson Cancer Center.

Schedule an appointment

We can help you schedule an appointment or you can search our directory of specialists.